Latest Blogs, Articles, and More View More >>
View More >>
With new treatments transforming multiple myeloma into a chronic condition and additional therapies on the horizon, some experts believe a cure is within view.
Cancer is more than cancer awareness and it isn’t just about the “popular” cancers.
The approval was based on findings from the phase 3 EF-14 trial.
A novel service model allowed for shorter durations of treatment with radiation, fewer unfinished treatments with radiation, shorter hospital stays and increased use of palliative care.
Researchers say breakthrough blood cancer therapies are worth the high cost. Other experts disagree.
I've often heard from people who've gone through traumatic experiences that their perspectives shifted and revealed previously unknown qualities.
The PD-1 inhibitor was approved along with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, and is indicated for patients who progressed on or after platinum-containing chemotherapy or EGFR- or ALK-targeted agents in patients harboring those mutations.